Last reviewed · How we verify

Magnetic Resonance Angiography (MRA) to evaluate adults with known or suspected renal occlusive vascular disease

1 treatments

Approved treatments

Competitive intelligence

For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:

Frequently asked questions about Magnetic Resonance Angiography (MRA) to evaluate adults with known or suspected renal occlusive vascular disease

What drugs treat Magnetic Resonance Angiography (MRA) to evaluate adults with known or suspected renal occlusive vascular disease?

Tracked treatments include MultiHance 0.1 mmol/kg.

What is the treatment for Magnetic Resonance Angiography (MRA) to evaluate adults with known or suspected renal occlusive vascular disease?

Standard treatment for Magnetic Resonance Angiography (MRA) to evaluate adults with known or suspected renal occlusive vascular disease includes MultiHance 0.1 mmol/kg. See the treatment landscape page for first-line, second-line and salvage options.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing